USP7 small-molecule inhibitors interfere with ubiquitin binding

No abstract is available for this paper.

• Publication year

  2017

• Venue

  Nature

• Publication date

  2017-10-18

• Fields of study

  Biology, Medicine, Chemistry

• Identifiers
  DOI 10.1038/nature24006PMID 29045385
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• p53 in the DNA-Damage-Repair Process.

  2016cited by this paper
• Reproducible pharmacogenomic profiling of cancer cell line panels

  2016cited by this paper
• Abstract LB-331: Comprehensive genomic analysis of malignant pleural mesothelioma identifies recurrent mutations, gene fusions and splicing alterations

  2016cited by this paper
• Ubiquitin-specific Protease-7 Inhibition Impairs Tip60-dependent Foxp3 + T-regulatory Cell Function and Promotes Antitumor Immunity

  2016cited by this paper
• DUBs, the regulation of cell identity and disease.

  2015cited by this paper
• A resource for cell line authentication, annotation and quality control

  2015cited by this paper
• Phosphorylation and linear ubiquitin direct A20 inhibition of inflammation

  2015cited by this paper
• Molecular mechanism for USP7-mediated DNMT1 stabilization by acetylation

  2015cited by this paper
• Structural Characterization of Interaction between Human Ubiquitin-specific Protease 7 and Immediate-Early Protein ICP0 of Herpes Simplex Virus-1*

  2015cited by this paper
• The demographics of the ubiquitin system.

  2015cited by this paper
• DUBs, the regulation of cell identity and disease.

  2015cited by this paper
• USP7 Acts as a Molecular Rheostat to Promote WASH-Dependent Endosomal Protein Recycling and Is Mutated in a Human Neurodevelopmental Disorder.

  2015cited by this paper
• Identifying recurrent mutations in cancer reveals widespread lineage diversity and mutational specificity

  2015cited by this paper
• Screening of DUB activity and specificity by MALDI-TOF mass spectrometry

  2014cited by this paper
• MDM2’s social network

  2014cited by this paper
• The landscape of somatic mutations in epigenetic regulators across 1,000 paediatric cancer genomes

  2014cited by this paper
• Proteotoxic crisis, the ubiquitin-proteasome system, and cancer therapy

  2014cited by this paper
• Deubiquitylases from genes to organism.

  2013cited by this paper
• Discovery of specific inhibitors of human USP7/HAUSP deubiquitinating enzyme.

  2012cited by this paper
• Ubiquitin-binding proteins: decoders of ubiquitin-mediated cellular functions.

  2012cited by this paper
• The ubiquitin code.

  2012cited by this paper
• The Multifaceted Roles of USP7: New Therapeutic Opportunities

  2011cited by this paper
• The differential modulation of USP activity by internal regulatory domains, interactors and eight ubiquitin chain types.

  2011cited by this paper
• Protein-linked Ubiquitin Chain Structure Restricts Activity of Deubiquitinating Enzymes*

  2011cited by this paper
• A General Chemical Ligation Approach Towards Isopeptide-Linked Ubiquitin and Ubiquitin-Like Assay Reagents

  2011cited by this paper
• For better or for worse: the role of Pim oncogenes in tumorigenesis

  2011cited by this paper
• Inactivation of HAUSP in vivo modulates p53 function

  2010cited by this paper
• Synergistic drug combinations improve therapeutic selectivity

  2009cited by this paper
• Tumour suppression: Disruption of HAUSP gene stabilizes p53

  2004cited by this paper
• A marker for Stevens–Johnson syndrome

  2004cited by this paper
• Crystal structure of a UBP-family deubiquitinating enzyme in isolation and in complex with ubiquitin aldehyde.

  2002cited by this paper

• Spotlights on ubiquitin-specific proteases in lung cancer: from multifaceted pathophysiological mechanisms to potential therapeutic targets

  2026cites this paper
• Deubiquitinase inhibitors: Targeting SARS-CoV-2 papain-like protease with antiviral efficacy in a murine model.

  2026cites this paper
• Discovery and characterization of potent macrocycle inhibitors of ubiquitin-specific protease-7.

  2025cites this paper
• Enantioselective OTUD7B fragment discovery through chemoproteomics screening and high-throughput optimisation

  2025cites this paper
• Small-molecule allosteric activator of ubiquitin-specific protease 7 (USP7).

  2025cites this paper
• Ubiquitin-specific proteases in pancreatic cancer: Molecular regulators of tumor progression and therapy resistance.

  2025cites this paper
• Deubiquitinase-Targeting Chimeras (DUBTACs) as a Potential Paradigm-Shifting Drug Discovery Approach.

  2025cites this paper
• Therapeutic potential of targeting ubiquitin-specific proteases in colorectal cancer.

  2025cites this paper
• Targeting the USP7-CDK1 axis suppresses estrogen receptor-positive breast cancer progression

  2025cites this paper
• USP7 Inhibitors Destabilize EBNA1 and Suppress Epstein‐Barr Virus Tumorigenesis

  2025cites this paper
• Smurf2 Suppresses Proliferation and Cell Cycle of Triple‐Negative Breast Cancer Cells by Promoting the Polyubiquitination and Degradation of RPL35A

  2025cites this paper
• Sialic acid-Retaled disorders: Advances in pathophysiology, diagnostic challenges, and differentiating mimics.

  2025cites this paper
• The diverse functions of ubiquitin-specific protease 47 and its role in diseases.

  2025cites this paper
• Structure-guided discovery of ubiquitin-specific protease 7 inhibitors through integrative quantitative structure-activity relationship modeling, docking, and molecular dynamics

  2025cites this paper
• USP7 at the Crossroads of Ubiquitin Signaling, Cell Cycle, and Tumorigenesis

  2025cites this paper
• Computational analysis of energetic features and intermolecular interactions in protein-inhibitor USP7 complexes.

  2025cites this paper
• Identification of USP39 as a prognostic and predictive biomarker for determining the response to immunotherapy in pancreatic cancer

  2025cites this paper
• Small-molecule allosteric activator of ubiquitin-specific protease 7 (USP7)

  2025cites this paper
• Pharmacologic interrogation of USP28 cellular function in p53 signaling.

  2025cites this paper
• USP7 deubiquitinase stabilizes FAN1 to support DNA crosslink repair and suppress CAG repeat expansion

  2025cites this paper
• The key vulnerabilities and therapeutic opportunities in the USP7-p53/MDM2 axis in cancer.

  2025cites this paper
• Recent advances in small molecule inhibitors of deubiquitinating enzymes.

  2025cites this paper
• Structures of USP7 in active and inactive states bound to DNMT1 revealed by cryo-EM.

  2025cites this paper
• Design, Synthesis, and Molecular Evaluation of SNAr‐Reactive N‐(6‐Fluoro‐3‐Nitropyridin‐2‐yl)Isoquinolin‐3‐Amines as Covalent USP7 Inhibitors Reveals an Unconventional Binding Mode

  2025cites this paper
• USP7 V517F mutation as a mechanism of inhibitor resistance

  2025cites this paper
• Non-catalytic UBL2 domain directs deubiquitinase USP11 toward K48-linked polyubiquitin chains

  2025cites this paper
• Chimeric deubiquitinase engineering reveals structural basis for specific inhibition of the mitophagy regulator USP30

  2025cites this paper
• The Hao-Fountain syndrome protein USP7 regulates neuronal connectivity in the brain via a novel p53-independent ubiquitin signaling pathway

  2025cites this paper
• Ubiquitin-Specific Protease Inhibitors for Cancer Therapy: Recent Advances and Future Prospects

  2025cites this paper
• Targeted protein degradation of Wnt/β-catenin signaling pathway: an effective strategy for cancer therapy

  2025cites this paper
• The Role of Ubiquitination and Deubiquitination in the Pathogenesis of Acute Kidney Injury: Progress in Research

  2025cites this paper
• Synthesis and identification of a novel selective USP7 degrader that inhibits the migration of upper gastrointestinal cancer cells without affecting proliferation.

  2025cites this paper
• The Small Molecule Compound Eupalinolide B Alleviates Neuropathic Pain by Regulating the USP7/Keap1/Nrf2 Pathway

  2025cites this paper
• Small Molecule‐Induced Alterations of Protein Polyubiquitination Revealed by Mass‐Spectrometric Ubiquitome Analysis

  2025cites this paper
• Assessing the Suitability of Deubiquitylases As Substrates For Targeted Protein Degradation

  2025cites this paper
• Ubiquitin-Specific Protease 7 (USP7) as a Promising Therapeutic Target for Drug Discovery: From Mechanisms to Therapies.

  2025cites this paper
• A NanoBRET-based assay monitoring interactions in the USP18 signaling hub identifies the first cell-penetrant small molecule compromising USP18/ISG15 binding

  2025cites this paper
• Molecular glues that inhibit deubiquitylase activity and inflammatory signaling

  2025cites this paper
• Unraveling the mechanisms of ubiquitin-specific proteases in hepatocellular carcinoma: A focus on inhibitors.

  2025cites this paper
• CREB binding protein (CREBBP): Structure-based perspectives for the development of clinical inhibitors

  2025influential citation
• Screening of Covalent Kinase Inhibitors Yields Hits for Cysteine Protease USP7 / HAUSP

  2025cites this paper
• Therapeutic targeting of ubiquitin-specific protease 7 (USP7): Mechanistic insights, dysregulation, and advances in drug discovery.

  2025cites this paper
• Discovery of o-aminodiphenyl-based USP7 inhibitor for immune activation and antitumor response in colorectal cancer.

  2025cites this paper
• Designer polyQ fusion proteins sequester USP7/HDM2 for modulating P53 functionality

  2025cites this paper
• Deubiquitinating Enzymes Ubiquitin-Specific Proteases 7 and 10 Regulate TAU Aggregation

  2025cites this paper
• USP7 deubiquitinates KRAS and promotes non-small cell lung cancer.

  2024cites this paper
• Drug screening approaches for small-molecule compounds in cancer-targeted therapy

  2024cites this paper
• PROTAC as a novel anti-cancer strategy by targeting aging-related signaling.

  2024cites this paper
• Targeting MYC: Multidimensional regulation and therapeutic strategies in oncology

  2024cites this paper
• Chimeric deubiquitinase engineering reveals structural basis for specific inhibition of USP30 and a framework for DUB ligandability

  2024cites this paper
• Identification of new leads against ubiquitin specific protease-7 (USP7): a step towards the potential treatment of cancers

  2024cites this paper
• Molecular glues that inhibit deubiquitylase activity and inflammatory signalling

  2024cites this paper
• DoUBLing up: ubiquitin and ubiquitin-like proteases in genome stability

  2024cites this paper
• The role of ubiquitination in health and disease

  2024cites this paper
• Recent advances and mechanisms of action of PD-L1 degraders as potential therapeutic agents.

  2024cites this paper
• USP36 inhibits apoptosis by deubiquitinating cIAP1 and survivin in colorectal cancer cells

  2024cites this paper
• Discovery of pyrrolo[2,3-d]pyrimidin-4-one derivative YCH3124 as a potent USP7 inhibitor for cancer therapy.

  2024cites this paper
• Working title: Molecular involvement of p53‐MDM2 interactome in gastrointestinal cancers

  2024cites this paper
• Structural basis for the bi-specificity of USP25 and USP28 inhibitors

  2024influential citation
• Structure-Guided Discovery of Selective USP7 Inhibitors with In Vivo Activity.

  2024cites this paper
• P53 upregulation by USP7-engaging molecular glues.

  2024cites this paper
• Ubiquitin-specific protease 7 inhibitors reveal a differentiated mechanism of p53-driven anti-cancer activity.

  2024cites this paper
• Drug resistance mechanisms and treatment strategies mediated by Ubiquitin-Specific Proteases (USPs) in cancers: new directions and therapeutic options

  2024cites this paper
• E3 ligases and DUBs target ferroptosis: A potential therapeutic strategy for neurodegenerative diseases.

  2024cites this paper
• Evaluation of a Covalent Library of Diverse Warheads (CovLib) Binding to JNK3, USP7, or p53

  2024cites this paper
• Backbone 1H, 13C and 15N resonance assignment of the ubiquitin specific protease 7 catalytic domain (residues 208–554) in complex with a small molecule ligand

  2024cites this paper
• Blocking Ubiquitin‐Specific Protease 7 Induces Ferroptosis in Gastric Cancer via Targeting Stearoyl‐CoA Desaturase

  2024cites this paper
• Inhibition of USP7 enhances CD8+ T cell activity in liver cancer by suppressing PRDM1-mediated FGL1 upregulation

  2024cites this paper
• USP7-Based Deubiquitinase-Targeting Chimeras Stabilize AMPK.

  2024cites this paper
• A comprehensive review: Protein homeostasis and an emerging therapeutic target.

  2024cites this paper
• Role of Ubiquitin-specific Proteases in Hepatocellular Carcinoma Pathogenesis.

  2024cites this paper
• Recent advances in the development of deubiquitinases inhibitors as antitumor agents.

  2024cites this paper
• Discovery of a Highly Potent, Selective and Efficacious USP7 Degrader for the Treatment of Acute Lymphoblastic Leukemia.

  2024cites this paper
• Virtual screening of natural products targeting ubiquitin-specific protease 7

  2024cites this paper
• USP7 inhibitors suppress tumour neoangiogenesis and promote synergy with immune checkpoint inhibitors by downregulating fibroblast VEGF

  2024cites this paper
• Tutorial review for peptide assays: An ounce of pre-analytics is worth a pound of cure.

  2023cites this paper
• Ubiquitin-specific protease 7 (USP7): an emerging drug target for cancer treatment

  2023cites this paper
• The USP46 deubiquitylase complex increases Wingless/Wnt signaling strength by stabilizing Arrow/LRP6

  2023cites this paper
• Cellular assays for dynamic quantification of deubiquitinase activity and inhibition.

  2023cites this paper
• Targeting ubiquitin specific proteases (USPs) in cancer immunotherapy: from basic research to preclinical application

  2023cites this paper
• The ubiquitin specific protease 7 stabilizes HPV16E7 to promote HPV-mediated carcinogenesis

  2023cites this paper
• Discovery of an OTUD3 inhibitor for the treatment of non-small cell lung cancer

  2023cites this paper
• Function, mechanism and drug discovery of ubiquitin and ubiquitin-like modification with multiomics profiling for cancer therapy

  2023cites this paper
• Structural Premise of Selective Deubiquitinase USP30 Inhibition by Small-Molecule Benzosulfonamides

  2023cites this paper
• USP7 Inhibition Suppresses Neuroblastoma Growth via Induction of p53-Mediated Apoptosis and EZH2 and N-Myc Downregulation

  2023cites this paper
• DNA nanoparticles targeting FOXO4 selectively eliminate cigarette smoke-induced senescent lung fibroblasts

  2023cites this paper
• USP7 controls NGN3 stability and pancreatic endocrine lineage development

  2023cites this paper
• The Pleiotropic Ubiquitin-Specific Peptidase 16 and Its Many Substrates

  2023cites this paper
• Recent Progress of Ubiquitin-Specific-Processing Protease 7 Inhibitors

  2023cites this paper
• UBE2C-mediated autophagy inhibition via ubiquitination of SIRT1 contributes to endometrial cancer progression.

  2023cites this paper
• Activation Dynamics of Ubiquitin Specific Protease 7

  2023cites this paper
• Multimodal data fusion for supervised learning-based identification of USP7 inhibitors: a systematic comparison

  2023cites this paper
• Targeting Myc-driven stress addiction in colorectal cancer.

  2023cites this paper
• What Strengthens Protein-Protein Interactions: Analysis and Applications of Residue Correlation Networks

  2023cites this paper
• Development of a robust HTRF assay with USP7 full length protein expressed in E. coli prokaryotic system for the identification of USP7 inhibitors.

  2023cites this paper
• Discovery and Characterization of BAY-805, a Potent and Selective Inhibitor of Ubiquitin-Specific Protease USP21

  2023cites this paper
• USP7 - a crucial regulator of cancer hallmarks.

  2023cites this paper
• SCML2 contributes to tumor cell resistance to DNA damage through regulating p53 and CHK1 stability

  2023cites this paper
• High-Throughput MALDI-TOF Mass Spectrometry-Based Deubiquitylating Enzyme Assay for Drug Discovery.

  2023cites this paper
• Ubiquitin-specific protease 7 prevents recurrent spontaneous abortion by targeting enhancer of zeste homolog 2 to regulate trophoblast proliferation, apoptosis, migration, and invasion through the Wnt/β-catenin pathway

  2023cites this paper